Myeloma Community Events - HealthTree for Multiple Myeloma

MC Events

Participate online and in person in live meetings led by experts in myeloma and attended by other myeloma patients. Participate and ask questions live.

Attend Our Community Driven Discussion: Gaps in Myeloma Education

August 03, 2023

Join our community driven discussion to identify common gaps in myeloma education or understanding.

Single Cell Sequencing in Myeloma

July 28, 2023

Dr. David Coffey, a myeloma specialist and researcher, shared with the myeloma community about his research surrounding single cell sequencing.

A Successful Columbus 5k (and 18k Raised for Research!)

June 15, 2023

Read about our successful event in Ohio with our supportive myeloma community.

Sequencing BCMA Therapies with Dr. Joshua Richter

April 26, 2023

Myeloma specialist, Dr. Joshua Richter, joins the Immunotherapy Chapter to discuss what we know about sequencing BCMA therapies.

The Hope of the Future in Black Myeloma Health Event Review

March 29, 2023

This was a remarkable and memorable meeting with three specialists who shared their hope for black myeloma.

What to Do with MRD Results: Starting or Changing Myeloma Treatment

November 15, 2022

Clinical trials help us understand what to do with MRD results. Learn more.

Understanding the Difference Between Chemo and Immunotherapies in Myeloma with Dr. Scott Goldsmith

August 12, 2022

Dr. Goldsmith explains the difference between immunotherapy and chemotherapy.

The Relationship Between Inflammation and Myeloma

May 02, 2022

Exploring the Relationship between Inflammation and Myeloma with Dr. Sarah Lee

How To Live with Myeloma Without Defining Yourself By It

April 20, 2022

The NorthEast Myeloma Crowd Community Chapter shares advice on how to live with myeloma without defining yourself by it.

How to Determine Whether or Not a Stem Cell Transplant is Successful with Dr. Guido Tricot

March 25, 2022

One of the leading myeloma specialists shares his insight on what constitutes a Stem Cell Transplant as successful or unsuccessful, and whether or not it still has a place in modern myeloma treatment.